Metabolomics and Precision Medicine in Resistant Hypertension: Pathophysiological Insights, Biomarker Discovery, and Translational Strategies.

Lee YR, Park M, Cho YS, Park HY

Open source

DOI
10.1155/ijhy/9656975
Published
2026
Container
International journal of hypertension
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/ijhy/9656975,
  title = {Metabolomics and Precision Medicine in Resistant Hypertension: Pathophysiological Insights, Biomarker Discovery, and Translational Strategies.},
  author = {Lee YR and Park M and Cho YS and Park HY},
  year = {2026},
  journal = {International journal of hypertension},
  doi = {10.1155/ijhy/9656975},
  url = {https://doi.org/10.1155/ijhy/9656975}
}

RIS

TY  - JOUR
TI  - Metabolomics and Precision Medicine in Resistant Hypertension: Pathophysiological Insights, Biomarker Discovery, and Translational Strategies.
AU  - Lee YR
AU  - Park M
AU  - Cho YS
AU  - Park HY
PY  - 2026
JO  - International journal of hypertension
DO  - 10.1155/ijhy/9656975
UR  - https://doi.org/10.1155/ijhy/9656975
ER  - 

APA

YR, L., M, P., YS, C., & HY, P. (2026). Metabolomics and Precision Medicine in Resistant Hypertension: Pathophysiological Insights, Biomarker Discovery, and Translational Strategies.. International journal of hypertension. https://doi.org/10.1155/ijhy/9656975

Source records